Waddah B. Al-Refaie, MD, FACS

Surgical Oncologist

Waddah B. Al-Refaie

Waddah B. Al-Refaie, MD, FACS is the founding chief of surgical oncology at MedStar Georgetown University Hospital and surgeon in chief of Georgetown Lombardi Comprehensive Cancer Center. He is also the director of the Surgical Outcomes Research Center, a joint program of MedStar Georgetown University Hospital and Lombardi Comprehensive Cancer Center.

He graduated from the Royal College of Surgeons in Dublin, Ireland in 1997, and completed his residency at the University of California, San Diego. He completed his fellowship at the University of Texas MD Anderson Cancer Center in 2006. Dr. Al-Refaie specializes in the treatment of gastrointestinal cancers, sarcomas, and other types of cancer, and is also interested in surgical outcomes research.

Dr. Al-Refaie’s expertise is in surgical and oncologic health services and outcomes research. Prior to his appointment at MedStar Georgetown University Hospital, he served at the University of Minnesota as an associate professor of surgery and co-director of the Minnesota Surgical Outcomes Research Center.

Dr. Al-Refaie serves on several national committees, including the Cancer in the Elderly Committee of the Alliance for Clinical Trials in Oncology and the Clinical Research Program, International Relations Committee and Cancer Care Delivery Research Committee of the American College of Surgeons. In addition, he has served as a mentor for more than 10 surgical oncology residents.

He is on the editorial board of the Journal of Global Surgery, serves as a reviewer for Annals of Surgical Oncology, CANCER and Diseases of the Colon and Rectum, and co-authored a book on breast cancer in Middle Eastern women. His research has been published in numerous peer-reviewed journals, includingAnnals of Surgical Oncology, JAMA Surgery and the Journal of the American College of Surgeons.

Dr. Al-Refaie is a fellow of the American College of Surgeons and an associate fellow of the Southwestern Surgical Congress. He has won numerous awards, including the Houston Surgical Society Award, the American Society of Clinical Oncology Foundation Merit Award, and an Advanced Care Practitioner Award from the University of Texas MD Anderson Cancer Center. He is past president of the Minneapolis Surgical Society and holds memberships in several other professional societies, including the Society of Surgical Oncology, the American Society of Breast Surgeons and the American Society of Clinical Oncology. He is a frequently invited speaker at meetings of professional societies, where he presents topics ranging from retroperitoneal sarcoma to surgical treatment of gastrointestinal stromal tumors. Dr. Al-Refaie is certified by the American Board of Surgery, and he is fluent in Arabic as well as English.